RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Crypto Analyst Sets Record Straight on Bitcoin's Potential $10K Surge
  2. Data Highlights Massive BTC Accumulation By Whales As 'Extreme Fear' Grips Bitcoin Price
  3. Crypto Winter Forces LocalBitcoins To Shut Down Operations
  4. If Bitcoin Is So Valuable, Why Is It Down So Much This Year?
  5. Here’s The Crucial Silver Lining To Tesla’s Bombshell $936 Million Bitcoin Sale